Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000987130 | SCV001136339 | likely pathogenic | Biotinidase deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001844252 | SCV002103643 | uncertain significance | not specified | 2024-06-05 | criteria provided, single submitter | clinical testing | Variant summary: BTD c.262A>G (p.Ile88Val) results in a conservative amino acid change located in the carbon-nitrogen hydrolase domain (IPR003010) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 249918 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.262A>G in individuals affected with Biotinidase Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 801944). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Baylor Genetics | RCV000987130 | SCV004211421 | likely pathogenic | Biotinidase deficiency | 2024-03-20 | criteria provided, single submitter | clinical testing |